Stem cell enrichment approaches.

Adult somatic tissue, and the tumours that arise therein, are maintained by a small population of stem cells. In addition to the self-renewal potential and pluripotency, these stem cells express several phenotypic traits that can be used in isolation and enrichment strategies. Since most of the traits are not exclusive to the stem cells however, the resultant populations are typically heterogeneous and variable from one isolation to another. In this article, we review the strategies for isolation of stem cells, and the limitations thereof, with emphasis on mesenchymal tissue and bone tumours. The emerging evidence suggests that stem cell is not a distinct entity, but rather an indefinite state along a spectrum, characterized by phenotypic traits, epigenetic factors and the microenvironment.

[1]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[2]  P. Nijweide,et al.  Removal of hematopoietic cells and macrophages from mouse bone marrow cultures: isolation of fibroblastlike stromal cells. , 1994, Experimental hematology.

[3]  J. Nolta,et al.  Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. , 2003, Blood.

[4]  J. Till,et al.  Perspectives on the properties of stem cells , 2005, Nature Medicine.

[5]  A. Benabid,et al.  Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. , 2004, Experimental cell research.

[6]  A. Friedenstein,et al.  Stromal stem cells: marrow-derived osteogenic precursors. , 1988, Ciba Foundation symposium.

[7]  P. Nowell,et al.  Chronic myelogenous leukemia: Laboratory diagnosis and monitoring , 2001, Genes, chromosomes & cancer.

[8]  P. Genever,et al.  Rapid isolation, expansion, and differentiation of osteoprogenitors from full-term umbilical cord blood. , 2005, Tissue engineering.

[9]  John T. Dimos,et al.  A Stem Cell Molecular Signature , 2002, Science.

[10]  J. Squire,et al.  Applications of SKY in Cancer Cytogenetics , 2002, Cancer investigation.

[11]  R. Hill.  Identifying cancer stem cells in solid tumors: case not proven. , 2006, Cancer research.

[12]  M. Kassem,et al.  Mesenchymal stem cells: cell biology and potential use in therapy. , 2004, Basic & clinical pharmacology & toxicology.

[13]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[15]  Rolf Bjerkvig,et al.  The origin of the cancer stem cell: current controversies and new insights , 2005, Nature Reviews Cancer.

[16]  Hermann Eichler,et al.  Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue , 2006, Stem cells.

[17]  G. Kopen,et al.  Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection , 2003, Journal of cellular biochemistry.

[18]  Jeremy J Mao,et al.  Mesenchymal stem cells: isolation and therapeutics. , 2004, Stem cells and development.

[19]  Ralf Huss,et al.  Isolation of Primary and Immortalized CD34− Hematopoietic and Mesenchymal Stem Cells from Various Sources , 2000, Stem cells.

[20]  Edward W Scott,et al.  Stem-like cells in bone sarcomas: implications for tumorigenesis. , 2005, Neoplasia.

[21]  Mina J Bissell,et al.  Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? , 2005, Cancer cell.

[22]  R. Class,et al.  Propagation and senescence of human marrow stromal cells in culture: a simple colony‐forming assay identifies samples with the greatest potential to propagate and differentiate , 1999, British journal of haematology.

[23]  Michael F. Clarke,et al.  Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.

[24]  L. Shihabuddin,et al.  Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction. , 2002, Tissue engineering.

[25]  S. Gronthos,et al.  Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow , 2003, Journal of Cell Science.

[26]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[27]  A. Flake,et al.  Mesenchymal stem cells: paradoxes of passaging. , 2004, Experimental hematology.

[28]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[29]  Max S Wicha,et al.  Cancer stem cells: an old idea--a paradigm shift. , 2006, Cancer research.

[30]  L. Shaffer,et al.  Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities , 1997, Human Genetics.

[31]  I. Black,et al.  Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis , 2002, Journal of neuroscience research.

[32]  R. McKay,et al.  CNS stem cells express a new class of intermediate filament protein , 1990, Cell.

[33]  R. Handgretinger,et al.  Biology and Plasticity of CD133+ Hematopoietic Stem Cells , 2003, Annals of the New York Academy of Sciences.

[34]  D. Krause,et al.  Suggestions for a new paradigm of cell differentiative potential. , 2001, Blood cells, molecules & diseases.

[35]  L. Lagneaux,et al.  Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential. , 2004, Cytotherapy.